Sonoma Pharmaceuticals, INC. (SNOA) — 10-K Filings
All 10-K filings from Sonoma Pharmaceuticals, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Sonoma Pharma's Sales Plunge 20% as Losses Mount to $10.5M
— Jun 17, 2025 Risk: high
Sonoma Pharmaceuticals, Inc. reported a significant decline in revenue for the fiscal year ended March 31, 2025, with net sales decreasing by 20.3% to $18.5 mil -
Sonoma Pharmaceuticals Files 2024 10-K
— Jun 17, 2024 Risk: medium
Sonoma Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending March 31, 2024. The company, formerly Oculus Innovative Sciences, Inc., is engaged in the
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX